Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

2.

Adenovirus-vectored drug-vaccine duo as a potential driver for conferring mass protection against infectious diseases.

Zhang J, Tarbet EB, Toro H, Tang DC.

Expert Rev Vaccines. 2011 Nov;10(11):1539-52. doi: 10.1586/erv.11.141. Review.

PMID:
22043954
3.

Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.

Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LC.

Vaccine. 2005 Mar 31;23(19):2430-8.

PMID:
15752829
4.

Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.

Remer KA, Bartrow M, Roeger B, Moll H, Sonnenborn U, Oelschlaeger TA.

Int J Med Microbiol. 2009 Nov;299(7):467-78. doi: 10.1016/j.ijmm.2009.03.003. Epub 2009 May 20.

PMID:
19467927
5.
6.

Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunity.

Zhang J, Shi Z, Kong FK, Jex E, Huang Z, Watt JM, Van Kampen KR, Tang DC.

Infect Immun. 2006 Jun;74(6):3607-17.

7.

Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.

Zhu C, Ruiz-Perez F, Yang Z, Mao Y, Hackethal VL, Greco KM, Choy W, Davis K, Butterton JR, Boedeker EC.

Vaccine. 2006 May 1;24(18):3821-31. Epub 2005 Jul 25.

PMID:
16098637
8.

Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans.

Turner AK, Terry TD, Sack DA, Londoño-Arcila P, Darsley MJ.

Infect Immun. 2001 Aug;69(8):4969-79. Erratum in: Infect Immun 2001 Oct;69(10):6564.

9.

Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen.

Katz DE, DeLorimier AJ, Wolf MK, Hall ER, Cassels FJ, van Hamont JE, Newcomer RL, Davachi MA, Taylor DN, McQueen CE.

Vaccine. 2003 Jan 17;21(5-6):341-6.

PMID:
12531630
10.

Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier.

Buddenborg C, Daudel D, Liebrecht S, Greune L, Humberg V, Schmidt MA.

Int J Med Microbiol. 2008 Jan;298(1-2):105-14. Epub 2007 Oct 23. Review.

PMID:
17936683
11.

Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.

Turner AK, Beavis JC, Stephens JC, Greenwood J, Gewert C, Thomas N, Deary A, Casula G, Daley A, Kelly P, Randall R, Darsley MJ.

Infect Immun. 2006 Feb;74(2):1062-71.

12.

Comparison of immune responses in parenteral FaeG DNA primed pigs boosted orally with F4 protein or reimmunized with the DNA vaccine.

Melkebeek V, Verdonck F, Goddeeris BM, Cox E.

Vet Immunol Immunopathol. 2007 Apr 15;116(3-4):199-214. Epub 2007 Feb 4.

PMID:
17331591
13.

Transcutaneous immunization: a human vaccine delivery strategy using a patch.

Glenn GM, Taylor DN, Li X, Frankel S, Montemarano A, Alving CR.

Nat Med. 2000 Dec;6(12):1403-6.

PMID:
11100128
14.

Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway.

Gentschev I, Mollenkopf H, Sokolovic Z, Hess J, Kaufmann SH, Goebel W.

Gene. 1996 Nov 7;179(1):133-40.

PMID:
8955639
15.

Hybrid vaccines using Escherichia coli as an antigen carrier.

Hale TL.

Res Microbiol. 1990 Sep-Oct;141(7-8):913-9. No abstract available.

PMID:
2101482
16.

Vaccination with attenuated Salmonella enterica Dublin expressing E coli O157:H7 outer membrane protein Intimin induces transient reduction of fecal shedding of E coli O157:H7 in cattle.

Khare S, Alali W, Zhang S, Hunter D, Pugh R, Fang FC, Libby SJ, Adams LG.

BMC Vet Res. 2010 Jul 7;6:35. doi: 10.1186/1746-6148-6-35.

17.

Expression and immunogenicity of enterotoxigenic Escherichia coli heat-labile toxin B subunit in transgenic rice callus.

Kim TG, Kim BG, Kim MY, Choi JK, Jung ES, Yang MS.

Mol Biotechnol. 2010 Jan;44(1):14-21. doi: 10.1007/s12033-009-9200-x. Epub 2009 Aug 6.

PMID:
19657748
18.

Immune response to Escherichia coli antigens entrapped in liposomes. I. Immunopathological studies.

Dima VF, Popescu C, Postoarcă A, Ionescu MD, Oproiu G, Lacky D, Balotescu C, Dima SV.

Roum Arch Microbiol Immunol. 1999 Jul-Dec;58(3-4):223-39.

PMID:
11845460
19.

Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant.

Cataldi A, Yevsa T, Vilte DA, Schulze K, Castro-Parodi M, Larzábal M, Ibarra C, Mercado EC, Guzmán CA.

Vaccine. 2008 Oct 16;26(44):5662-7. doi: 10.1016/j.vaccine.2008.07.027. Epub 2008 Sep 21.

PMID:
18675866
20.

Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.

Zhang XH, He KW, Zhang SX, Lu WC, Zhao PD, Luan XT, Ye Q, Wen LB, Li B, Guo RL, Wang XM, Lv LX, Zhou JM, Yu ZY, Mao AH.

Vaccine. 2011 May 17;29(22):3923-9. doi: 10.1016/j.vaccine.2011.02.007. Epub 2011 Feb 21.

PMID:
21338683

Supplemental Content

Support Center